Literature DB >> 21825883

Predicting response to neoadjuvant treatment for rectal cancer: a step toward individualized medicine.

Rodrigo Oliva Perez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21825883     DOI： 10.1097/DCR.0b013e31822182ce

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  4 in total

1.  Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.

Authors:  Lin Wang; Xiao-Mei Zhang; Zhen Li; Xi-Jun Liu; Jie Chai; Guang-Yong Zhang; Yu-Feng Cheng
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

2.  hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy.

Authors:  Jianming Qiu; Guangen Yang; Zhong Shen; Ya Xie; Lewei Wang
Journal:  Int J Colorectal Dis       Date:  2012-07-17       Impact factor: 2.571

Review 3.  [Complete response after neoadjuvant therapy of rectal cancer: implications for surgery].

Authors:  Carolin Kastner; Bernhard Petritsch; Joachim Reibetanz; Christoph-Thomas Germer; Armin Wiegering
Journal:  Chirurg       Date:  2021-12-08       Impact factor: 0.955

4.  XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.

Authors:  Chang-Jiang Qin; Xin-Ming Song; Zhi-Hui Chen; Xue-Qun Ren; Kai-Wu Xu; Hong Jing; Yu-Long He
Journal:  Oncotarget       Date:  2015-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.